Evaxion A (EVAX) Long-Term Deferred Tax (2020 - 2025)

Evaxion A (EVAX) reported Long-Term Deferred Tax of $23.2 million for Q4 2025, up 13.36% on a YoY basis from $20.4 million in Q4 2024, and up 13.36% quarter-over-quarter from $20.4 million in Q4 2024.

Evaxion A (EVAX) Long-Term Deferred Tax (2020 - 2025) Analysis & Trends

Evaxion A has reported Long-Term Deferred Tax for 6 years, with the latest figure at $23.2 million in Q4 2025.

  • For the quarter ending Q4 2025, Long-Term Deferred Tax rose 13.36% year-over-year to $23.2 million; the trailing twelve-month figure through Dec 2025 stood at $23.2 million (up 13.36% YoY), and the FY2025 full-year result was $23.2 million, up 13.36% from the prior year.
  • Long-Term Deferred Tax for Q4 2025 stood at $23.2 million, up from $20.4 million in the prior quarter.
  • The five-year high for Long-Term Deferred Tax was $23.2 million in Q4 2025, with the low at $133000.0 in Q3 2021.
  • Historically, Long-Term Deferred Tax has averaged $9.1 million across 5 years, with a median of $739000.0 in 2022.
  • Annual changes were most pronounced in 2023 — Long-Term Deferred Tax surged 2474.02% — and 2024, when it rose 7.4%.
  • Evaxion A's Long-Term Deferred Tax stood at $133000.0 in 2021, then soared by 455.64% to $739000.0 in 2022, then surged by 2474.02% to $19.0 million in 2023, then advanced by 7.4% to $20.4 million in 2024, then climbed by 13.36% to $23.2 million in 2025.
  • The last three Long-Term Deferred Tax figures came in at $23.2 million (Q4 2025), $20.4 million (Q4 2024), and $19.0 million (Q4 2023), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn -
7 Psyence Biomedical 212.16 Bn 212.16 Bn -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn
9 Abivax 91.96 Bn 91.96 Bn -
10 Regeneron Pharmaceuticals 63.43 Bn 54.67 Bn 3.31 Bn

Historic Data

Download Data
DateValue
Dec 31, 2025 23.16 Mn
Dec 31, 2024 20.43 Mn
Dec 31, 2023 19.02 Mn
Dec 31, 2022 739,000.00
Sep 30, 2021 133,000.00
Jun 30, 2021 252,000.00
Mar 31, 2021 179,000.00
Dec 31, 2020 262,000.00